Condition: Nasopharyngeal Cancinoma (NPC) · Sponsor: Sun Yat-sen University
To evaluate the locoregional control, survival rate, toxicity, and quality of life in patients with nasopharyngeal carcinoma treated with reduced prophylactic irradiation doses to the Low-Risk Clinical Target Volume (CTV).
This description comes directly from the study's public registry record.
Hai-Qiang Mai, Ph. D. · +86-020-87343643 · maihq@sysucc.org.cn
Always discuss trial participation with your own doctor first.
| Dongguan People's Hospital | Dongguan, Guangdong, China | Recruiting |
| Sun yat-sen university cancer center | Guangzhou, Guangdong, China | Recruiting |
| Affiliated Cancer Hospital of Shantou University Medical College | Shantou, Guangdong, China | Recruiting |
| Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center | Shenzhen, Guangdong, China | Recruiting |
| The University of Hong Kong-Shenzhen Hospital | Shenzhen, Guangdong, China | Recruiting |
| Affiliated Hospital of Guangdong Medical University | Zhanjiang, Guangdong, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07201337